Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL431734 | 0.86 | KDM4E (0.40) | TSHRKDM4EALOX15ALDH1A1 | |
| Acrylamide SCHEMBL3822742 | 0.85 | ALDH1A1 (0.42) | TSHRKDM4EALDH1A1 | |
| SCHEMBL9461327 | 0.81 | KDM4E (0.59) | TSHRKDM4EALOX15ALDH1A1 | |
| SCHEMBL9461328 | 0.81 | KDM4E (0.59) | TSHRKDM4EALOX15ALDH1A1 | |
| SCHEMBL11880753 | 0.80 | KMT2A (0.57) | KDM4EALOX15ALDH1A1 | |
| SCHEMBL11880747 | 0.80 | KMT2A (0.57) | KDM4EALOX15ALDH1A1 | |
| Methyl Alcohol SCHEMBL28949472 | 0.77 | ALDH1A1 (0.35) | TSHRKDM4EALDH1A1 | |
| SCHEMBL18808379 | 0.77 | PYCR1 (0.35) | TSHRALOX15 | |
| SCHEMBL20656 | 0.76 | TSHR (0.43) | TSHRKDM4EALDH1A1 | |
| SCHEMBL7549527 | 0.76 | TSHR (0.43) | TSHRKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5202497-A | Catalytic oxidation of allylic tertiary amines | RHONE-POULENC NUTRITION ANIMALE (FR) | 1993-04-13 | — | — | US | claimed |
| JP-58177943-A | — | — | None | — | — | JP | disclosed |
| EP-1142859-B2 | Process for producing optically active 3,7-dimethyl-6-octenol and process for producing intermediate therefore | TAKASAGO PERFUMERY CO LTD (JP) | 2010-04-28 | — | — | EP | disclosed |
| EP-1142859-B1 | Process for producing optically active 3,7-dimethyl-6-octenol and process for producing intermediate therefore | TAKASAGO PERFUMERY CO LTD (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-6489522-B2 | ORGANOLEPTIC; FROM ALKYLAMINE AND ISOPRENE; CATALYTIC ISOMERIZATION, HEATING | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-12-03 | — | — | US | disclosed |
| US-6486353-B2 | SUBJECTING MIXTURE OF ALKYLAMINE AND ISOPRENE TO TELOMERIZATION AT 80-100 DEGREES C.IN THE PRESENCE OF AN ALKYLLITHIUM AND/OR PHENYLLITHIUM CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-11-26 | — | — | US | disclosed |
| US-20020128525-A1 | Process for producing optically active 3,7-dimethyl-6-octenol and process for producing intermediate therefor | TAKASAGO INTERNATIONAL CORPORATION | 2002-09-12 | — | — | US | disclosed |
| US-20020004620-A1 | Process for producing optically active 3, 7-dimethyl-6-octenol and process for producing intermediate therefor | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-01-10 | — | — | US | disclosed |
| EP-1142859-A2 | Process for producing optically active 3,7-dimethyl-6-octenol and process for producing intermediate therefor | Takasago International Corporation (JP) | 2001-10-10 | — | — | EP | disclosed |
| US-5202497-A | Catalytic oxidation of allylic tertiary amines | RHONE-POULENC NUTRITION ANIMALE (FR) | 1993-04-13 | — | — | US | disclosed |
| JP-S58177943-A | PREPARATION OF DIALKYLFARNESYLAMINE | TAKASAGO CORP | 1983-10-18 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128525-A1 | Process for producing optically active 3,7-dimethyl-6-octenol and process for producing intermediate therefor | NOTUM, CYP51A1, SOAT2 | TSHR 2910/4885KDM4E 1835/4885ALOX15 219/4885 |
| US-20020004620-A1 | Process for producing optically active 3, 7-dimethyl-6-octenol and process for producing intermediate therefor | NOTUM, CYP51A1, SOAT1 | TSHR 3026/4885KDM4E 1921/4885ALOX15 245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.